Next Quarterly Earnings
Thursday, August 6, 2026
CW 32
After-Hours
In 32 days
Organogenesis Holdings
Organogenesis Holdings is a leading US-based biotechnology company specializing in Regenerative Medicine products. It develops and markets innovative therapies for advanced wound care, as well as solutions for orthopedic surgery and sports medicine. The company utilizes biopharmaceuticals and tissue engineering to promote healing and improve patient outcomes.
All Dates
Earnings history data not available
Company Information
Name
Organogenesis Holdings
Country
🇺🇸
More Financial Information